Overview

Phase 2 Clinical Trial to Investigate the Safety, Tolerability and Efficacy of YH1885L in Patients With Non-erosive Reflux Disease(NERD)

Status:
Completed

Trial end date:
2014-04-01

Target enrollment:

Participant gender:

Summary

Randomized, double-blind, active-controlled, multi-center phase 2 clinical trial to investigate the safety, tolerability and efficacy of YH1885L in patients with non-erosive reflux disease(NERD)

Phase:

Phase 2

Details

Lead Sponsor:

Yuhan Corporation

Treatments:

Esomeprazole